Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Potassium channel KIR4.1-specific antibodies in children with acquired demyelinating CNS disease.
Neural correlates of alerting and orienting impairment in multiple sclerosis patients.
Oral fingolimod reduces glutamate-mediated intracortical excitability in relapsing-remitting multiple sclerosis.
Does Slowed Processing Speed Account for Executive Deficits in Multiple Sclerosis? Evidence From Neuropsychological Performance and Structural Neuroimaging.
Cell fusion in the brain: two cells forward, one cell back.
Managing treatment fatigue in patients with multiple sclerosis on long-term therapy: the role of multiple sclerosis nurses.
The hepatocyte growth factor (HGF)-MET receptor tyrosine kinase signaling pathway: Diverse roles in modulating immune cell functions.
The Choroid Plexus in Healthy and Diseased Brain.
Patient and equipment profile for wheelchair seating clinic provision.
Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study.
Medical marijuana in neurology.
The high cost of spasticity in multiple sclerosis to individuals and society.
Histone deacetylase activity is required for human oligodendrocyte progenitor differentiation.
[Amino acids content in the blood serum of patients with multiple sclerosis.]
Aquatic training in MS: neurotherapeutic impact upon quality of life.
Cortical excitability changes over time in progressive multiple sclerosis.
Blocking LINGO-1 as a Therapy to Promote CNS Repair: From Concept to the Clinic.
Coincidence of spinal tumor (astrocytoma) and non-specific encephalomyelitis.
Estrogen inhibits estrogen receptor(ER) α-mediated rho-kinase expression in experimental autoimmune encephalomyelitis rats.
Gene Therapy of Multiple Sclerosis Using Interferon β -Secreting Human Bone Marrow Mesenchymal Stem Cells.
Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results.
The TRUST (EvaluaTion of Bladder Function in Relapsing-Remitting MUltiple Sclerosis Patients Treated with Natalizumab) Observational Study.
[Optic Neuritis.]
Inflammation-independent defective early B cell tolerance checkpoints in rheumatoid arthritis.
Initiation of Anti-TNF Therapy and the Risk of Optic Neuritis; From the Safety Assessment of Biologic ThERapy (SABER) Study.

Pages